Samara Zaifman

Cooley advised Life360, a family connection and safety company, on its $178.5 million initial public offering.

Cooley advised Carmot Therapeutics, a clinical-stage biotechnology company dedicated to developing life-changing therapeutics for people living with metabolic diseases including obesity and diabetes, on its definitive merger agreement in which Roche will acquire Carmot.

Cooley, which represents more than 600 digital health clients across the healthcare ecosystem, advised One Medical, a human-centered, technology-powered national primary care organization, on a definitive merger agreement under which Amazon will acquire One Medical for $18 per share in an all-cash transaction valued at approximately $3.9 billion, including One Medical’s net debt. Lawyers Steven Tonsfeldt, Matthew Hemington, Anne Lieberman and Gaël Hagan are leading the Cooley team advising One Medical.

Cooley advised ThoughtSpot, a modern analytics cloud company, on its $100 million Series F financing round, which brings its valuation to $4.2 billion. Lawyers David Ambler, Mary Wilbourn and Allie Frappier led the Cooley team advising ThoughtSpot.

Cooley advised Cytek Biosciences on its $200 million initial public offering of 14,564,635 shares of common stock. Cytek Biosciences, whose securities now trade on the Nasdaq Global Select Market under the symbol CTKB, is a leading cell analysis solutions company. Partners Gordon Ho, Patrick Loofbourrow and John McKenna led the Cooley team.